» Articles » PMID: 28965116

New Anti-Nephrin Antibody Mediated Podocyte Injury Model Using a C57BL/6 Mouse Strain

Overview
Journal Nephron
Publisher Karger
Specialty Nephrology
Date 2017 Oct 2
PMID 28965116
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Focal segmental glomerulosclerosis (FSGS) is considered a subset of the podocytopathies. The molecular pathogenesis of podocytopathy is still unknown. There has not been an experimental animal model of isolated podocytopathy induced by antibody in C57BL/6 strain, which is widely used as the genetic background. Nephrin is closely associated with the slit diaphragm of the glomerular podocyte, and has recently received attention as a potential therapeutic target. The function of nephrin, especially its role in FSGS development via podocytopathy, is being elucidated. We report our experience with a C57BL/6 FSGS model induced by polyclonal rabbit anti-mouse nephrin antibody (α-mNep Ab).

Methods: α-mNep Ab, which was generated by genetic immunization, was administered into C57BL/6 mice at once, intravenously. Urinary protein excretion, the development of glomerulosclerosis and the number of podocyte in mouse kidney were evaluated.

Results: The α-mNep Ab-induced FSGS was associated with massive proteinuria and nephrotic syndrome. In periodic acid-Schiff staining, FSGS was observed from day 7 after antibody injection. Podocyte numbers and podocyte marker (anti-Wilms tumor 1 and anti-synaptopodin)-positive areas were clearly decreased. These results suggest that this FSGS mouse model reliably reproduces the human nephrotic syndrome and FSGS.

Conclusion: We succeeded in making the nephrotic syndrome model mice induced by α-mNep Ab using C57BL/6. This model may be useful for studying the mechanisms of podocytopathy.

Citing Articles

Anti-nephrin antibody: a potential biomarker of minimal change disease.

Chen Q, Chen S, Ye Q, Lin W, Liao Y, Xiong Y Clin Kidney J. 2025; 18(3):sfaf012.

PMID: 40046822 PMC: 11879414. DOI: 10.1093/ckj/sfaf012.


The Pathogenesis of Nephrotic Syndrome: A Perspective from B Cells.

Zhu S, Zhang J, Gao L, Ye Q, Mao J Kidney Dis (Basel). 2024; 10(6):531-544.

PMID: 39664337 PMC: 11631018. DOI: 10.1159/000540511.


Antinephrin-Associated Primary Focal Segmental Glomerulosclerosis Successfully Treated With Plasmapheresis.

Bressendorff I, Nelveg-Kristensen K, Ghasemi M, Watts A, Elversang J, Keller K Kidney Int Rep. 2024; 9(9):2829-2831.

PMID: 39291184 PMC: 11403026. DOI: 10.1016/j.ekir.2024.06.038.


Clinical Characteristics of Nephrin Autoantibody-Positive Minimal Change Disease in Older Adults.

Fujita Y, Watts A, Ichikawa D, Shibagaki Y, Suzuki T, Keller K Kidney Int Rep. 2024; 9(8):2563-2566.

PMID: 39156160 PMC: 11328551. DOI: 10.1016/j.ekir.2024.05.003.


Anti-nephrin autoantibodies: a paradigm shift in podocytopathies.

Cui Z, Zhao M Nat Rev Nephrol. 2024; 20(10):639-640.

PMID: 39080046 DOI: 10.1038/s41581-024-00873-7.